New study aims to uncover mysteries of rare SITRAME syndrome
NCT ID NCT07168746
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will collect information from 100 people in France with SITRAME syndrome, a rare autoinflammatory disease. Researchers want to learn about the disease's symptoms, treatments, and outcomes. No new treatments are being tested; the goal is simply to better understand the condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide the first clear picture of how SITRAME syndrome affects people in France, helping doctors recognize and manage it better.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test any new therapy, and results may take years to gather and analyze.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTO INFLAMMATORY DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.